Product image of Laxygal (Sodium Picosulfate) supplied by GNH India

Laxygal

Active Ingredient:
Sodium Picosulfate
Origin:
EU

Laxygal (Sodium Picosulfate)

Sodium picosulfate, the active ingredient in Laxygal, is a stimulant laxative presented as an oral formulation for oral use. It is employed to relieve constipation and to prepare the bowel for diagnostic examinations such as colonoscopy in adult patients. The drug is marketed in the European Union and complies with relevant regulatory standards for quality and safety.

GNH India supplies Laxygal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with established distribution networks across Europe, Asia and the Americas.

Manufacturer / TM Owner

Teva B.V

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Sodium picosulfate is used as a stimulant laxative to promote bowel evacuation in several clinical situations.

  • Constipation: facilitates regular bowel movements by increasing intestinal peristalsis and water content.
  • Colonoscopy preparation: clears the colon to improve visualization during the procedure.
  • Other diagnostic bowel preparation: used before radiologic examinations such as sigmoidoscopy or barium enema to achieve adequate cleansing.

How It Works

  • After oral administration, sodium picosulfate reaches the colon where resident bacteria convert it to an active metabolite that stimulates the enteric nerves. This activation enhances colonic smooth‑muscle contractions (peristalsis) and promotes secretion of electrolytes and water into the lumen, resulting in accelerated transit and softened stool. The effect typically begins within a few hours and lasts until the bowel is cleared.

Side Effects

Sodium picosulfate may cause a range of adverse reactions, varying from mild to serious.

Common Side Effects

  • Abdominal cramps: mild to moderate discomfort in the lower abdomen.
  • Diarrhea: loose, watery stools occurring after dosing.
  • Nausea: feeling of queasiness without vomiting.
  • Flatulence: increased intestinal gas.

Serious or Rare Side Effects

  • Severe dehydration: marked loss of fluids leading to dizziness or low blood pressure.
  • Electrolyte imbalance: abnormal levels of sodium, potassium or chloride.
  • Allergic reaction: rash, itching, swelling or difficulty breathing.

Precautions & Warnings

When prescribing sodium picosulfate, clinicians should consider several safety measures to minimise risks.

  • Assess renal function: impaired kidneys may affect fluid balance.
  • Review electrolyte status: pre‑existing abnormalities increase risk of imbalance.
  • Avoid concurrent use with other laxatives: may cause excessive bowel stimulation.
  • Caution in patients with inflammatory bowel disease: may exacerbate symptoms.
  • Pregnancy and lactation: use only if clearly needed after risk‑benefit evaluation.
  • Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Avoid Interactions

Sodium picosulfate can interact with certain medicines, altering its efficacy or safety profile.

Major Interactions (Avoid)

  • Anticholinergic agents: may reduce laxative effect.
  • Opioid analgesics: can counteract stimulant action and cause constipation.
  • Diuretics: increase risk of dehydration and electrolyte disturbances.

Moderate Interactions (Monitor Closely)

  • Mineral supplements (e.g., calcium, iron): may decrease absorption of the drug.
  • Antihypertensive drugs: enhanced hypotensive effect due to fluid loss.
  • NSAIDs: potential for renal impairment when combined with dehydration.

Frequently Asked Questions

Laxygal contains sodium picosulfate, a stimulant laxative indicated for the relief of occasional constipation and for bowel cleansing prior to diagnostic procedures such as colonoscopy, sigmoidoscopy or radiologic examinations that require a clear colon.

After oral intake, colonic bacteria convert sodium picosulfate into an active metabolite that stimulates the enteric nerves, increasing peristaltic activity and promoting secretion of water and electrolytes into the intestinal lumen, which together accelerate stool transit and soften the stool.

The appropriate dose of Laxygal is determined by the prescribing healthcare professional based on the patient’s condition, age, and clinical response. Patients should follow the specific instructions provided by their prescriber and not adjust the dose on their own.

Safety of sodium picosulfate during pregnancy or lactation has not been definitively established. It should only be used when clearly needed after a careful risk‑benefit assessment by the prescriber, and alternative treatments may be considered when possible.

To request Laxygal, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Laxygal (sodium picosulfate) is a stimulant laxative that acts locally in the colon, whereas osmotic laxatives such as polyethylene glycol draw water into the bowel, and bulk‑forming agents increase stool volume. Sodium picosulfate typically produces a rapid, predictable bowel movement, making it suitable for scheduled bowel preparation.

Laxygal should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiry date indicated on the label.

Laxygal is taken orally, usually as a tablet or powder that is dissolved in water, according to the prescriber’s instructions. It is typically consumed with a full glass of water and may be followed by additional clear fluids as directed to aid bowel cleansing.

The most serious risks include severe dehydration and electrolyte disturbances, which can lead to low blood pressure, dizziness, or cardiac arrhythmias. Rarely, an allergic reaction may occur, presenting as rash, swelling, or breathing difficulty, requiring immediate medical attention.

Laxygal should be avoided in individuals with known hypersensitivity to sodium picosulfate, in patients with acute intestinal obstruction, severe inflammatory bowel disease flare, or uncontrolled electrolyte imbalances. It is also contraindicated in those for whom bowel preparation is medically inadvisable.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.